NDC 70261-512

Dex-Moxi PF

Dexamethasone - Moxifloxacin Pf

Dex-Moxi PF is a Intraocular Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Imprimisrx Nj. The primary component is Dexamethasone Sodium Phosphate; Moxifloxacin Hydrochloride Monohydrate.

• Product ID: 70261-512_6bb78fd2-5d73-1b41-e053-2991aa0af497
• NDC: 70261-512
• Product Type: Human Prescription Drug
• Proprietary Name: Dex-Moxi PF
• Generic Name: Dexamethasone - Moxifloxacin Pf
• Dosage Form: Injection, Solution
• Route of Administration: INTRAOCULAR
• Marketing Start Date: 2018-01-01
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: ImprimisRx NJ
• Substance Name: DEXAMETHASONE SODIUM PHOSPHATE; MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE
• Active Ingredient Strength: 1 mg/mL; mg/mL
• Pharm Classes: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Quinolone Antimicrobial [EPC],Quinolones [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 70261-512-01

1 mL in 1 VIAL, SINGLE-USE (70261-512-01)

• Marketing Start Date: 2018-01-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 70261-512-01 [70261051201]

Dex-Moxi PF INJECTION, SOLUTION

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2018-01-01
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
DEXAMETHASONE SODIUM PHOSPHATE	1 mg/mL

OpenFDA Data

• SPL SET ID: 6bb78fd2-5d72-1b41-e053-2991aa0af497
• Manufacturer:
  • ImprimisRx NJ
• UNII:
  • B8956S8609
  • AI9376Y64P

Pharmacological Class

• Corticosteroid [EPC]
• Corticosteroid Hormone Receptor Agonists [MoA]
• Quinolone Antimicrobial [EPC]
• Quinolones [CS]